[Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction].
BACKGROUND
Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulation, infertility and hyperandrogenism, and the prevalence of this condition in women of reproductive is 5-10%. The growth of early ovarian antral follicles is arrested and dominant follicle selection is disturbed in this syndrome.


OBJECTIVE
The aim of this study is to investigate whether inhibin B serum concentrations represent the extent of ovarian abnormalities in patients with PCOS.


METHODS
Inhibin B serum concentrations on the third day of spontaneous menstrual cycle and other endocrine characteristics were compared between 20 patients with PCOS and 19 healthy women in the control group.


RESULTS
Inhibin B concentrations were not significantly different between women with PCOS and women in the control group. In patients with PCOS there was statistically significant correlation between serum inhibin B and LH (r = 0.514; p = 0.021).There were no positive correlations between inhibin B and others endocrine parameters in patients with PCOS (FSH, E2,T, androstenedione).


CONCLUSIONS
Inhibin B serum concentrations on the third day of spontaneous menstrual cycle in women with PCOS are not different from the concentrations in healthy women. Serum Inhibin B levels in patients with PCOS are only slightly correlated with the endocrine markers of the disease so it could not represent the magnitude of ovarian dysfunction in this syndrome.
Cetković
Aleksandar
A
D000328:Adult; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D007265:Inhibins / Q000097:blood*; D008597:Menstrual Cycle; D010053:Ovary / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000175:diagnosis / Q000503:physiopathology
D015415:Biomarkers; C422364:inhibin B; D007265:Inhibins